Insmed (INSM) Reports Q4 Loss, Tops Revenue Estimates

Insmed (INSM) came out with a quarterly loss of $1.32 per share versus the Zacks Consensus Estimate of a loss of$ 1.15. This compares to loss of $1.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -14.78%. A quarter ago, it was expected that this biopharmaceutical developing inhaled treatments for patients battling rare lung diseases would post a loss of$ 1.19 per share when it actually produced a loss of $1.27, delivering a ...